- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05343182
Vestibulectomy Surgical Techniques Comparison Study
November 4, 2023 updated by: Catherine M Leclair, MD, Oregon Health and Science University
Vestibulectomy: A Prospective Comparison of Two Surgical Techniques for the Treatment of Provoked Localized Vulvodynia (PVD)
Vestibulectomy Surgical Techniques Comparison Study
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Vestibulectomy: A Prospective Comparison of Two Surgical Techniques for the treatment of Provoked Localized Vulvodynia (PVD)
Study Type
Interventional
Enrollment (Estimated)
118
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Women's Health Research Unit Confidential Recruitment Line
- Phone Number: 503-494-3666
- Email: whru@ohsu.edu
Study Locations
-
-
Oregon
-
Portland, Oregon, United States, 97239
- Recruiting
- Oregon Health and Science University
-
Contact:
- Women's Health Research Unit Confidential Recruitment Line
- Phone Number: 503-494-3666
- Email: whru@ohsu.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Reported provoked tenderness to the vestibule for at least 3 months in non-pregnant, estrogen-replete healthy subjects aged 18 years or over meeting Friedrich's criteria for PVD44-45 and supported by the ISSVD Terminology Consensus Definition45 for vulvar pain. Subjects who are >45years of age must have either have a maturation index52 of < 10% parabasal cells or willingness to participate in local estrogen replacement until achieving this same clinical result.
- Cotton swab Test30-31 mean verbal rating score of ≥4/10 in 4 of 6 defined points of the vestibule (2, 4, 6, 8, 10, 12 o'clock) and cotton swab test verbal score ≤ 2/10 for the labia majora and minora, intra labial sulcus, and perineum
- Ability to insert a regular Tampax® tampon
- Baseline Tampon Test verbal pain score ≥430
f. Phone and internet access e. Willingness to engage in pelvic floor physical therapy (PT)
Exclusion Criteria:
- Pregnancy
- Any other clinical reason for dyspareunia (endometriosis pain, chronic pelvic pain, vulvar dermatoses such as psoriasis, lichen sclerosus)
- Unable or unwilling to complete baseline assessments
- Prior vestibulectomy or hymen surgery
- Prior or current use of testosterone dosed for gender affirmation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Modified Vestibulectomy
|
This operation is performed using modified anesthesia care/deep sedation (MAC) for anesthesia.
The vestibule is removed to the boundary of Harts line.
The surgical flap for this procedure is the Hymen plus 1 cm of the vagina.
|
|
Active Comparator: Traditional Vestibulectomy
|
This operation is performed using an Laryngeal Mask Airway (LAM), (modified anesthesia care/deep sedation) for anesthesia.
The vestibule is removed 0.5 to 1 cm beyond the boundary of the Hart's line.
The Hymen plus 1 cm of the vagina is excised.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Tampon Test pain scores from baseline to 3 months
Time Frame: Baseline visit to 3 months after surgery
|
The change from baseline in pain measured by the Tampon Test at 3 months after surgery.
The tampon test is a validated tool used to measure (vulva) vestibular skin pain by having participants insert and remove a tampon.
Participants will be asked to rate their pain along a 100 mm Visual Analog Scale on a scale of 0 (No pain) to 10 (Pain as bad as you can imagine).
This test will occur at baseline and 3 months follow up.
|
Baseline visit to 3 months after surgery
|
|
Change in pain scores from baseline to 6 months
Time Frame: Baseline visit to 6 months after surgery
|
The change from baseline in pain measured by the Tampon Test at 6 months after surgery.
The tampon test is a validated tool used to measure (vulva) vestibular skin pain by having participants insert and remove a tampon.
Participants will be asked to rate their pain along a 100 mm Visual Analog Scale on a scale of 0 (No pain) to 10 (Pain as bad as you can imagine).
This test will occur at baseline and 6 months follow up.
|
Baseline visit to 6 months after surgery
|
|
Change in pain scores from baseline to 12 months
Time Frame: Baseline visit to 12 months after surgery
|
The change from baseline in pain measured by the Tampon Test at 12 months after surgery.
The tampon test is a validated tool used to measure (vulva) vestibular skin pain by having participants insert and remove a tampon.
Participants will be asked to rate their pain along a 100 mm Visual Analog Scale on a scale of 0 (No pain) to 10 (Pain as bad as you can imagine).
This test will occur at baseline and 12 months follow up.
|
Baseline visit to 12 months after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Catherine Leclair, MD, Oregon Health and Science University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 6, 2022
Primary Completion (Estimated)
June 1, 2024
Study Completion (Estimated)
June 1, 2025
Study Registration Dates
First Submitted
April 18, 2022
First Submitted That Met QC Criteria
April 18, 2022
First Posted (Actual)
April 25, 2022
Study Record Updates
Last Update Posted (Actual)
November 7, 2023
Last Update Submitted That Met QC Criteria
November 4, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- OHSU IRB 24107
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vulvodynia
-
University Hospital, GhentCompletedLocalized Provoked VulvodyniaBelgium
-
Oregon Health and Science UniversityMedical Research Foundation, OregonCompleted
-
Meir Medical CenterCompleted
-
McLean Center for Complementary and Alternative...UnknownVulvodynia | Vulvar Vestibulitis | Vulvodynia, Generalized | Vulvar PainUnited States
-
Meir Medical CenterCompletedLocalized Provoked VulvodyniaIsrael
-
Uppsala UniversityCompletedVulvodynia, Generalized | Provoked VestibulodyniaSweden
-
Oregon College of Oriental MedicineOregon Health and Science University; National Vulvodynia Association; Council...CompletedVulvodynia | Vulvar Vestibulitis | Provoked Vestibulodynia | Provoked, Localized VulvodyniaUnited States
-
Colleen StockdaleTerminatedVulvar Pain Symptoms | Vulvodynia (Chronic Vulvar Pain)United States
-
University of TennesseeUniversity of Tennessee Health Science CenterCompleted
-
Western Galilee Hospital-NahariyaCompleted
Clinical Trials on Modified Technique
-
Postgraduate Institute of Dental Sciences RohtakCompleted
-
Seoul National University HospitalCompletedComplications of Central Venous CatheterizationKorea, Republic of
-
University of BaghdadRecruiting
-
Cairo UniversityUnknownImplant Complication
-
Korea University Anam HospitalSeoul National University Hospital; Kyungpook National University Chilgok Hospital and other collaboratorsEnrolling by invitationRectal Cancer | Rectal Neoplasms | Rectal Neoplasms Malignant | Rectal Cancer SurgerySouth Korea
-
Seoul National University HospitalCompletedCatheterization, Central VenousKorea, Republic of
-
Johannes Gutenberg University MainzCompletedObesity | Difficult Airway | CricothyroidotomyGermany
-
Ankara Yildirim Beyazıt UniversityNot yet recruitingDental Caries | Pediatric Dentistry | Dental OcclusionTurkey (Türkiye)
-
Khon Kaen HospitalCompletedAnterior Shoulder DislocationThailand
-
Necmettin Erbakan UniversityCompleted